RodneyPRocconiMD
Obstetrics & Gynecology • Mobile, ALGynecologic Oncology
Elsie Colle Chair of Oncology Research Associate Director Clinical Research, Professor of Gynecologic Oncology University of South Alabama Mitchell Cancer Institute
Dr. Rocconi is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1660 Springhill Avenue
Mobile, AL 36640Phone(251) 665-8000
Fax(251) 665-8010- Is this information wrong?
Education & Training
University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 2000 - 2004
University of Alabama School of MedicineClass of 2000
Certifications & Licensure
AL State Medical License 2001 - 2021- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial Start of enrollment: 2012 Jan 01Benjamin, I.,Mannel, R.S.,Moore, K.N.,Morgan, R.E.,Scribner, D.R.,Thigpen, J.T.
- A Randomized Phase II Evaluation of Weekly Paclitaxel (NSC #673089) Plus Pazopanib (NSC #737754) (IND #75648) Versus Weekly Paclitaxel Plus Placebo in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcin Start of enrollment: 2012 Jan 01Behrens, R.J.,Carolla, R.L.,Eddy, G.L.,Greer, B.E.,Mannel, R.S.,Miller, M.A.,Morris, P.C.,Morrissey, T.P.,Mutch, D.G.,Puls, L.E.,Richardson, D.L.,Rocconi, R.P.,Sharma, S.K.,Spirtos, N.M.,Sutton, G.P.
- Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer Start of enrollment: 2010 Oct 01Rocconi, R.P.
- A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus or Ovary Start of enrollment: 2009 Aug 01Abbas, F.M.,Abulafia, O.,Anderson, D.M.,Behrens, R.J.,Benjamin, I.,Boothby, R.A.,Borowsky, M.E.,Bosscher, J.R.,Boulay, R.M.,Buekers, T.E.,Bury, M.J.,Carolla, R.L.,Cha, S.,Chambers, S.K.,Cloven, N.G.,Colli...
- A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma Start of enrollment: 2009 Jun 01Abbas, F.M.,Abulafia, O.,Anderson, D.M.,Atkins, J.N.,Bae, D.,Behrens, R.J.,Benjamin, I.,Berman, M.L.,Blank, S.V.,Boothby, R.A.,Borowsky, M.E.,Boulay, R.M.,Bristow, R.E.,Buckley, S.L.,Buekers, T.E.,Burke, ...
- A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, In Stage IVB, Recurrent or Start of enrollment: 2009 Apr 01Abbas, F.M.,Abulafia, O.,Agarwala, S.S.,Anderson, M.L.,Atkins, J.N.,Basil, J.,Behrens, R.J.,Bell, M.C.,Benjamin, I.,Berman, M.L.,Blank, S.V.,Boothby, R.A.,Borowsky, M.E.,Boulay, R.M.,Bristow, R.E.,Buekers...
- A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed By Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma Start of enrollment: 2009 Mar 01Abbas, F.M.,Abulafia, O.,Arango, H.A.,Basil, J.,Behrens, R.J.,Benjamin, I.,Berman, M.L.,Borowsky, M.E.,Bristow, R.E.,Brockmeyer, A.D.,Buekers, T.E.,Burke, W.M.,Carney, M.E.,Carolla, R.L.,Cass, I.,Chamberl...
Publications & Presentations
PubMed
- Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.Rodney P. Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. C. Chan, Minal Barve, Jonathan Oh, Devansu Tewari, Peter C. Morris, Erin E. Stevens, Justin N. Bott...> ;Lancet Oncology. 2020 Dec 1
- Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance.Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis,...> ;Gynecologic oncology reports. 2020 Sep 17
- Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor recep...Patel, G. K., Perry, J. B., Abdul-Rahim, O., Frankel, A. E., Cameron, D., Taylor, W., Rocconi, R. P., Abushahin, L., Nelson, C., Singh, A. P., Khushman, M.> ;Journal of cancer research and therapeutics. 2020 Sep 16
- Join now to see all
Press Mentions
Why Are More Black Women Dying from the Most Common Reproductive Cancer?October 21, 2019 21:59
USA Health Mitchell Cancer Institute Studies Published for 2019 ASCO MeetingJune 03, 2019 21:57- USA Health’s Ajay Singh Honored by Society of Asian American Scientists in Cancer ResearchMay 06, 2019 20:12
- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- Mobile Infirmary Medical CenterMobile, Alabama
- USA Health Children's & Women's HospitalMobile, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
